| 000 | 01863 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517192308.0 | ||
| 264 | 0 | _c20190528 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1521-0103 | ||
| 024 | 7 |
_a10.1124/jpet.117.244129 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHilberg, Frank | |
| 245 | 0 | 0 |
_aTriple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _c03 2018 |
||
| 300 |
_a494-503 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xpathology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 |
_aLung Neoplasms _xpathology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aOncogenes _xgenetics |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aProto-Oncogene Mas |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aTontsch-Grunt, Ulrike | |
| 700 | 1 | _aBaum, Anke | |
| 700 | 1 | _aLe, Anh T | |
| 700 | 1 | _aDoebele, Robert C | |
| 700 | 1 | _aLieb, Simone | |
| 700 | 1 | _aGianni, Davide | |
| 700 | 1 | _aVoss, Tilman | |
| 700 | 1 | _aGarin-Chesa, Pilar | |
| 700 | 1 | _aHaslinger, Christian | |
| 700 | 1 | _aKraut, Norbert | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 364 _gno. 3 _gp. 494-503 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.117.244129 _zAvailable from publisher's website |
| 999 |
_c27910837 _d27910837 |
||